Print this page

Balance Sheet of the Merck Group 

XLS

€ million

June 30,
2011

December 31,
2010

Current assets

 

 

Cash and cash equivalents

1,355.3

943.7

Marketable securities and financial assets

362.2

55.6

Trade accounts receivable

2,306.3

2,296.3

Inventories

1,644.9

1,673.5

Other current assets

355.9

564.7

Tax receivables

59.1

93.7

Assets held for sale

36.7

 

6,083.7

5,664.2

Non-current assets

 

 

Intangible assets

11,702.6

12,484.1

Property, plant and equipment

3,022.0

3,241.5

Investments at equity

3.7

5.0

Non-current financial assets

145.1

130.3

Financial assets covering pensions

219.4

216.9

Other non-current assets

61.0

52.9

Deferred tax assets

652.5

593.1

 

15,806.3

16,723.8

 

 

 

Total assets

21,890.0

22,388.0

 

 

 

Current liabilities

 

 

Current financial liabilities

968.1

356.1

Trade accounts payable

1,056.0

1,200.1

Other current liabilities

862.7

1,054.6

Tax liabilities

345.3

368.4

Current provisions

322.7

374.5

Liabilities directly related to assets held for sale

5.9

 

3,554.7

3,359.6

Non-current liabilities

 

 

Non-current financial liabilities

4,533.4

5,127.4

Other non-current liabilities

8.6

42.9

Non-current provisions

514.0

524.2

Provisions for pensions and other
post-employment benefits

1,609.2

1,581.6

Deferred tax liabilities

1,317.5

1,380.5

 

7,982.7

8,656.6

Net equity

 

 

Equity capital

565.2

565.2

Reserves

8,488.8

8,484.2

Gains/losses recognized immediately in equity

1,256.8

1,280.4

Equity attributable to shareholder of the parent company

10,310.9

10,329.8

Non-controlling interest

41.7

42.0

 

10,352.6

10,371.8

 

 

 

Total liabilities and stockholders’ equity

21,890.0

22,388.0

© Merck KGaA, Darmstadt, Germany, Last Update 2011/07/27